Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the last 3 years of the pandemic situation, SARS-CoV-2 caused a significant number of deaths. Infection rates for symptomatic and asymptomatic patients are higher than that for death. Eventually, researchers explored that the major deaths are attributed to several comorbidity factors. The confounding factors and gender-associated infection/death rate are observed globally. This suggests that SARS-CoV-2 selects the human system recognizing the internal comorbid environment. This article explored the influences of hypertension, diabetes, cardiovascular, and renovascular disorders in COVID-19 severity and mortality. Brief mechanistic layouts have been presented here, indicating some of the comorbidity as the critical determinant in the COVID-19 pathogenesis and related mortality.

Cite

CITATION STYLE

APA

Santra, D., Banerjee, A., De, S. K., Thatoi, H., & Maiti, S. (2023, April 1). Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity. Comparative Clinical Pathology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00580-023-03434-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free